UT Southwestern Medical Center, Dallas, TX, USA.
Hand (N Y). 2022 Mar;17(2):231-238. doi: 10.1177/1558944720926638. Epub 2020 Jun 2.
There is a paucity of literature exploring the impact of smoking on short-term complications, readmissions, and reoperations after elective upper extremity surgery using a large multicenter national database. We hypothesized that smokers will have an increased rate of complications, readmissions, and reoperations compared with a cohort of nonsmokers undergoing elective upper extremity surgery. Patient data were collected from the American College of Surgeons National Surgical Quality Improvement Program database between the years 2012 and 2017. Patients were included if they underwent elective surgery of the upper extremity using 338 predetermined Current Procedural Terminology codes. The data collected were divided into patient demographics, comorbidities, perioperative variables, and 30-day complications. Current smoking status was defined as smoking within 1 year prior to surgery. The incidence of surgical complications, reoperations, and readmissions was compared between the 2 cohorts using multivariable regression analysis. Of the 107 943 patients undergoing elective surgeries of the upper extremity, 73 806 met the inclusion criteria. Of these, 57 986 (78.6%) were nonsmokers in the year prior to surgery, and 15 820 (21.4%) were current smokers. Between these groups, current smokers were younger ( < .001), more often men ( < .001), had lower body mass index ( < .001), and more often underwent procedures that involved bone manipulation ( < .001). Multivariate regression analysis defined current smoking as significantly associated with overall surgical site complications, superficial surgical site infections, deep surgical site infections, reoperation, and readmission. Current smoking was significantly associated with an increase in all surgical site complications, readmissions, and reoperations after elective upper extremity surgery. Surgeons should consider smoking a modifiable risk factor for postoperative complications and appropriately counsel patients on outcomes and complications given the elective nature of upper extremity surgery.
目前,使用大型多中心国家数据库探讨吸烟对择期上肢手术短期并发症、再入院和再次手术的影响的文献很少。我们假设与接受择期上肢手术的非吸烟队列相比,吸烟者的并发症、再入院和再次手术的发生率更高。
患者数据来自美国外科医师学会国家手术质量改进计划数据库,时间为 2012 年至 2017 年。如果患者接受了使用 338 个预定的当前操作术语代码的择期上肢手术,则将其纳入研究。收集的数据包括患者人口统计学特征、合并症、围手术期变量和 30 天并发症。当前吸烟状态定义为手术前 1 年内吸烟。使用多变量回归分析比较两组之间的手术并发症、再次手术和再入院的发生率。
在 107943 例接受择期上肢手术的患者中,有 73806 例符合纳入标准。其中,57986 例(78.6%)在手术前 1 年内为非吸烟者,15820 例(21.4%)为当前吸烟者。在这两组之间,当前吸烟者年龄更小(<.001),男性更多(<.001),体重指数更低(<.001),并且更多地进行涉及骨骼操作的手术(<.001)。多变量回归分析将当前吸烟定义为与总手术部位并发症、浅表手术部位感染、深部手术部位感染、再次手术和再入院显著相关。
当前吸烟与择期上肢手术后所有手术部位并发症、再入院和再次手术显著相关。鉴于上肢手术的选择性,外科医生应将吸烟视为术后并发症的可改变危险因素,并适当向患者提供有关手术结果和并发症的咨询。